IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01126-07v1
76/6/2767    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glover, D. T.
Right arrow Articles by Briles, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glover, D. T.
Right arrow Articles by Briles, D. E.

 Previous Article  |  Next Article 

Infection and Immunity, June 2008, p. 2767-2776, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01126-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Streptococcus pneumoniae Surface Protein PcpA Elicits Protection against Lung Infection and Fatal Sepsis{triangledown}

David T. Glover,1 Susan K. Hollingshead,1 and David E. Briles1,2*

Departments of Microbiology,1 Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama2

Received 13 August 2007/ Returned for modification 19 September 2007/ Accepted 26 March 2008

Previous studies have suggested that pneumococcal choline binding protein A (PcpA) is important for the full virulence of Streptococcus pneumoniae, and its amino acid sequence suggests that it may play a role in cellular adherence. PcpA is under the control of a manganese-dependent regulator and is only expressed at low manganese concentrations, similar to those found in the blood and lungs. PcpA expression is repressed under high manganese concentrations, similar to those found in secretions. In this study, we have demonstrated that PcpA elicits statistically significant protection in murine models of pneumonia and sepsis. In the model of pneumonia with each of four challenge strains, statistically fewer S. pneumoniae cells were recovered from the lungs of mice immunized with PcpA and alum versus mice immunized with alum only. The immunizations reduced the median CFU by 4- to 400-fold (average of 28-fold). In the model of sepsis using strain TIGR4, PcpA expression resulted in shorter times to become moribund and subcutaneous immunization with PcpA increased survival times of mice infected with wild-type PcpA-expressing pneumococci.

* Corresponding author. Mailing address: University of Alabama at Birmingham, BBRB 658, 1530 3rd Ave. S., Birmingham, AL 35294-2170. Phone: (205) 934-6595. Fax: (205) 934-0605. E-mail: dbriles{at}uab.edu

{triangledown} Published ahead of print on 7 April 2008.

Editor: J. N. Weiser

Infection and Immunity, June 2008, p. 2767-2776, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01126-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.